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Abstract: Cerium oxide nanoparticles (CeO2-NPs) have great applications in different industries,
including nanomedicine. However, some studies report CeO2-NPs-related toxicity issues that limit
their usage and efficiency. In this study, the sol–gel method was applied to the synthesis of CeO2-NPs
using poly(allylamine) (PAA) as a capping and/or stabilizing agent. The different molecular weights
of PAA (15,000, 17,000, and 65,000 g/mol) were used to investigate the physico-chemical and biological
properties of the NPs. In order to understand their performance as an anticancer agent, three cell lines
(MCF7, HeLa, and erythrocyte) were analyzed by MTT assay and RBC hemolysis assay. The results
showed that the CeO2-NPs had anticancer effects on the viability of MCF7 cells with half-maximal
inhibitory concentration (IC50) values of 17.44 ± 7.32, 6.17 ± 1.68, and 0.12 ± 0.03 µg/mL for PAA15000,
PAA17000, PAA65000, respectively. As for HeLa cells, IC50 values reduced considerably to 8.09
± 1.55, 2.11 ± 0.33, and 0.20 ± 0.01 µg/mL, in order. A decrease in the viability of cancer cells was
associated with the 50% hemolytic concentration (HC50) of 0.022 ± 0.001 mg/mL for PAA15000, 3.74
± 0.58 mg/mL for PAA17000, and 7.35 ± 1.32 mg/mL for PAA65000. Ultraviolet-Visible (UV-vis)
spectroscopy indicated that an increase in the PAA molecular weight led to a blue shift in the bandgap
and high amounts of Ce3+ on the surface of the nanoceria. Thus, PAA65000 could be considered as
a biocompatible nanoengineered biomaterial for potential applications in cancer nanomedicine.
Keywords: nanoceria; cancer cells; hemolytic activity; nanomedicine
1. Introduction
Nanotechnology, after nearly three decades, has opened up plenty of opportunities for the evolution
of multifarious advanced materials in numerous products with prospective biomedical applications [1–
3]. Metal centers are considered a key element of solids with extensive 2D or 3D structures and
also biological macromolecules that render excellent properties and functions [4]. In this regard,
cerium oxide nanoparticles (CeO2-NPs) were of great interest in medicine [5–8]. Cerium belongs
to the lanthanide series that exists in abundance on the earth’s surface, at up to 0.0046%, and has
the highest water solubility among the rare earth elements. It is the most reactive rare earth element
after europium. Cerium is a potent oxidizing agent that can be rapidly oxidized when exposed to
atmospheric oxygen [9,10]. Cerium is present in both the tetravalent (Ce4+) and trivalent (Ce3+) states.
The following synonyms are frequently used for CeO2: Cerium dioxide, cerium oxide, cerium (IV) oxide,
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ceric oxide, and ceria [9]. CeO2 is applied to a miscellany of purposes, such as semiconductors [11],
cigarette additives [9], and predominantly diesel fuel [12]. What is more, CeO2-NPs have unique
properties that make them good candidates for various medical applications, like drug delivery
systems [13], biosensors [14], and imaging techniques [15].
However, naked nanoceria are poorly water-soluble, which restricts its applications for biomedical
purposes. Recent investigations suggest the polymer coating of nanoceria as an influential solution
to the issues of weak stability, poor biocompatibility, and low water solubility [16]. Poly(allylamine)
(PAA) is a cationic polymer with a large number of amino groups and displays great water-soluble and
biodegradable properties [17,18]. Several studies support the use of PAA in nanoparticulate systems
to enhance their efficiency in designing new therapeutic products [19–21]. In this work, based on
the positive contribution of PAA to the development of functional materials, a simple sol–gel route
was utilized to prepare biocompatible CeO2–NPs with anticancer effects. To this end, PAA was used
as a capping and/or stabilizing agent, which expands during the calcination process, and protects
particles from agglomeration.
2. Materials and Methods
2.1. Chemicals and Reagents
All the materials used in the present work were of an analytical grade. Cerium nitrate hexahydrate
[Ce(NO3)·6H2O, 99%] was purchased from Samchun (Seoul, Korea), and PAA with three different
molecular weights of 65,000 (20 wt.% in H2O), 17,000 (20 wt.% in H2O), and 15,000 (10 wt.% in H2O)
g/mol was procured from Polysciences. Ammonium hydroxide (NH4OH, 25 vol%; Merck, Darmstadt,
Germany), and glacial acetic acid (Merck, Darmstadt, Germany) were used for the synthesis of
nanoparticles. HeLa (human cervical adenocarcinoma) and MCF-7 (human breast cancer) cell lines were
obtained from the Pasteur Institute of Iran (IPI). Phosphate Buffered Saline (PBS), streptomycin, trypsin,
penicillin, dimethyl sulfoxide (DMSO), and 3-(4, 5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium
bromide (MTT) were acquired from Sigma-Aldrich (Saint Louis, MO, USA). Fetal Bovine Serum (FBS;
10%) and Dulbecco’s Modified Eagle’s Medium (DMEM) were obtained from GIBCO (Carlsbad, CA,
USA). N-(2-Hydroxyethyl) piperazine-N’-(2-ethane sulfonic acid) (HEPES) (Sigma-Aldrich, Steinheim,
Germany), Triton X-100 (Merck, Darmstadt, Germany), and V-bottom 96-well plate (Sigma-Aldrich,
Steinheim, Germany) were utilized to evaluate the hemolytic activity of the CeO2-NPs. Double distilled
water was used for all experiments.
2.2. Synthesis of CeO2-NPs
The CeO2-NPs were prepared by the sol–gel method using PAA (15,000, 17,000, and 65,000 g/mol)
as an organic template. Briefly, 20.0 g of cerium nitrate hexahydrate and 5.0 gr of PAA were added
separately to 100 mL of distilled water. Then, the cerium nitrate solution was mixed slowly with
the PAA solution by vigorous stirring for 30 min. Afterward, 1 M ammonium hydroxide was added to
the solution in a drop-wise fashion until the final pH became approximately 10. Glacial acetic acid
was applied to adjust pH in the final solution. The obtained suspension was stirred at 70 ◦C for 10 h
until the citrine color resin (gel-like material) was achieved. The precipitate was finally obtained by
centrifuging and washing in order to remove the remaining nitrate, ammonia, and organic impurities.
The result of thermogravimetric/differential thermal analysis (TGA/DTA, TA Instruments SDT Q600)
revealed that the calcination temperature must be 400 ◦C. Therefore, the collected samples were heated
in an electric muffle furnace (Finetech, Seoul, Korea) at 400 ◦C at a constant rate of 5 ◦C/min and
maintained at this temperature for 2 h to obtain “light” citrine CeO2-NPs.
2.3. Characterization of CeO2-NPs
The thermal behavior of the synthesized CeO2-NPs was analyzed employing a TGA/DrTGA
device (TA Instruments SDT Q600). Around 5 mg of the NP samples were heated up to 1000 ◦C in an
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air atmosphere at the heating rate of 10 ◦C/min. Moreover, the NPs were characterized by powder
X-ray diffraction (PXRD), Field Emission Scanning Electron Microscope (FESEM), Fourier-transform
infrared (FTIR) spectroscopy, and UV-Visible (UV-vis) spectrophotometry. The PXRD was carried
out by using a Philips X’pert diffractometer (USA) equipped with Cu Kα (λ = 1.54056 A) radiation in
the range between 10◦ and 80◦ (2θ). The PXRD patterns of the NPs were obtained at a scan speed of
2◦/min. The mean particle size (D) of the prepared CeO2-NPs was calculated from the XRD data using
the Scherrer equation:
D = 0.94λ/βcosθ (1)
where 0.94 is taken as the shape factor, λ is the X-ray wavelength for CuKα radiation (0.15406 nm),
θ is the Bragg diffraction angle, and β is the full-width at half-maximum (FWHM) of the (1 1 1)
diffraction peak.
The shape and morphology, along with the particle size distribution of the NPs were recorded
by a Carl Zeiss SUPRA 55VP FESEM (Wetzlar, Germany) with an operating voltage in the range of
20–30 kV. The FTIR spectroscopy was conducted within the range of 400–4000 cm−1 to determine
the surface and chemical composition of the NPs. The spectra were recorded applying an ST-IR\ST-SIR
spectrometer (Thermo Scientific, Waltham, MA, USA) after 64 scans. The optical absorption spectra
of the NPs were analyzed employing a UV-vis spectrophotometer (Evolution 300® Thermo-Fisher
Scientific, Dreieich, Germany) over the range of 200–800 nm.
2.4. Evaluation of Cytotoxicity Effects
The cytotoxicity and half-maximal inhibitory concentration (IC50) of the NPs were evaluated
by the MTT assay [22]. Briefly, HeLa and MCF7 cell lines were cultured in high glucose DMEM
medium (1 g/L glucose, 2 mM glutamine) supplemented by 10% (v/v) FBS, 100 units/mL penicillin,
and 100 µg/mL streptomycin. These cells were then incubated at 37 ◦C under damp air conditions
(90% relative humidity) with 5% CO2. After three days, the non-adherent cells were segregated by
replacing the medium with a fresh one, while the anchorage-dependent cancer cells were expanded
further through two passages. Subsequently, the cells were harvested from culture flasks via treatment
with trypsin (0.25%) and seeded overnight at a density of 1 × 104 cells per well in a 96-well plate. After
that, the cells were exposed to the various concentrations (10 dilutions) of the NPs for 24 h. In the next
step, 10 µL of 5 mg/mL MTT in the PBS buffer were added to each well and allowed for 4-h incubation
at 37 ◦C. Following DMSO (100 µL) addition, optical absorbance was recorded at 540 and 630 nm
(reference wavelength) using a plate reader (Stat FAX 2100, Awareness Technology, San Jose, CA, USA).
All experiments were carried out five times [23,24].
2.5. Hemolytic Activity of CeO2-NPs
Human fresh blood was centrifuged at 3000 rpm for 10 min at 4 ◦C. The cell pellet was rinsed with
PBS four times (followed by centrifugation under the mentioned conditions) and then diluted ten-fold
in 150 mM NaCl. Moreover, the calcined CeO2-NPs at 400 ◦C were suspended in a stock solution of
1 mg/mL HEPES-buffered saline (HBS; 150 µL). Thus, the various concentrations of the CeO2-NPs were
prepared in a V-bottom 96-well plate using triplicates. The negative control was 150 µL of HBS, with
150 µL of 1% Triton X-100 acting as the positive control. After that, the erythrocyte mixture (20 µL) was
poured into each well, and the plates were incubated for 45 min at 37 ◦C under continuous shaking.
The supernatant (70 µL) was separated by centrifugation at 3000 rpm for 10 min and used for the next
evaluation of hemoglobin release. Measurements were performed at 405 nm on a plate reader [25].
One metric for measuring hemolytic activity is HC50, i.e., the concentration of the NPs that kills 50% of
RBCs [26].
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2.6. Statistical Analysis
All data were displayed as a mean ± standard deviation (SD) and further compared running
one-way ANOVA. A p < 0.05 was defined as the significance level of the present study. GraphPad
Prism (Ver. 6.01) and GraphPad InStat (Ver. 3.10) were used to conduct the statistical analyses.
3. Results and Discussion
3.1. FTIR Spectroscopy
The FTIR spectra of the CeO2–NPs using PAA15000, PAA17000, and PAA65000 are illustrated in
Figure 1. The presence of the cubic CeO2 was detected by the FTIR studies. Of the most characteristic
bands, there was an intense peak at ~550 cm−1 corresponding to the phonon mode of the cubic CeO2.
The strong absorption peak at 470 cm−1 exhibited the Ce-O stretching. In addition, the absorption
bands were respectively found at 1620 and 3430 cm−1 representing the ν (OH) mode of (H-bonded)
water molecules and δ (OH) [27]. No peak for the NO stretch was detected by the FTIR analysis,
revealing that the washing procedure omitted the trace amount of nitrate. Furthermore, the absorption
peaks in the range of 1400–1500 cm−1 corresponded to the bending vibrations of -CH groups [28].
Figure 1. FTIR spectra of CeO2–NPs.
3.2. Thermal Analysis
The color of the sol–gel-derived CeO2–NPs was changed from brown to white because of
the increased calcination temperature. Figure 2 displays the TGA/DrTGA curves of the as-prepared
PAA-based gels. Since the same thermal behavior was observed for all molecular weights of
PAA, TGA/DrTGA measurements are described for the samples with the PAA molecular weight of
15,000 g/mol. The thermogravimetric analysis showed three main regions of weight loss. The first
region, with a weight loss of 55.11% of the initial weight, was in the range between 25 and 185 ◦C
due to the evaporation of the initial water and the partial decomposition of PAA. In the next region,
weight loss (26.82% of the initial weight) occurred from 185 to 236 ◦C as a result of the decomposition
of the chemically bonded groups. The final region, from 236 to 462 ◦C, had a weight loss of 3.4% of
the initial weight that may arise from the formation and decomposition of the pyrochlore phases, as
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well as the crystallization of the CeO2 pure phases. There was no weight loss between 462 and 950 ◦C
on the TGA curve, implying that the nanocrystalline CeO2 was formed as the decomposition product.
Figure 2. TGA/DrTGA curves of the as-prepared gels with (a) PAA15000 and (b) PAA17000.
3.3. PXRD Analysis
The PXRD patterns of the CeO2-NPs are presented in Figure 3. All of the detectable peaks were
indexed with Miller indices (hkil = 1 1 1, 2 0 0, 2 2 0, 3 1 1, 2 2 2, 4 0 0, 3 3 1, and 4 2 0), which
were consistent with the cubic fluorite-type structure of CeO2 (JCPDS # 01-089-8436); this structure
had a main orientation of the (1 1 1) reflection plane. The PXRD data confirmed the high quality
of the CeO2–NPs [no peak indicative of possible intermediate phases, including Ce(OH)4/Ce(OH)3].
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Moreover, it was found that the PXRD peaks became less sharp, and FWHM decreased after calcination
at 400 ◦C for 2 h, suggesting that the crystallinity of the CeO2–NPs was deteriorated as the PAA
molecular weight increased.
Figure 3. Powder X-ray diffraction (PXRD) patterns of CeO2–NPs.
3.4. FESEM Analysis
The FESEM image and size distribution of the CeO2–NPs are demonstrated in Figure 4 at various
magnifications. As can be seen, the synthesized CeO2–NPs had the form of spherical aggregations.
These particles were small in size, with an average size of 46.24, 28.58, and 45.52 nm (less than
50 nm [22]) when PAA15000, PAA17000, and PAA65000 were used, respectively. These findings were
in line with the PXRD data and could explain the broadening of the peaks. According to the FESEM
images, the nano-sized particles were uniform in morphology, and the use of PAA-65000 led to the NPs
with a narrower size distribution.
Polymers 2020, 12, 1444 7 of 14
Figure 4. FESEM images of CeO2–NP prepared by (a) PAA15000, (b) PAA17000, (c) PAA65000.
3.5. Optical Properties of Calcined Nanoceria
In Figure 5, the UV-vis spectra exhibited a strong absorption peak at <299 nm for the CeO2–NPs
aqueous dispersion with PAA65000, which is evidence for the presence of Ce3+ on the surface of
the nanoceria. On the contrary, the CeO2–NPs aqueous dispersion with PAA15000 and PAA17000 had
a characteristic absorption peak at >360. In the pertinent literature, it has been reported that Ce3+ and
Ce4+ absorb light within the range of 230–260 nm and 300–400 nm, respectively [29]. On the whole,
the oxidized state of cerium (Ce4+) constitutes the main content of a nanoceria crystal. When the crystal
size reduces, the surface defects linked to oxygen vacancies elevate, which, in turn, raises Ce3+ on
the surface. The ratio of Ce4+/Ce3+ plays a pivotal role in the mechanism whereby nanoceria scavenge
reactive oxygen species (ROS) [30]. The absorption peak in the UV region is more likely to arise from
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the electronic transitions corresponding to the electronic excitation of O(2p) state to Ce(4f) orbitals
and the spin–orbit coupling of 3d orbitals [22,31]. What is more, the sharp peak for the CeO2–NPs
prepared by PA65000 confirmed their narrow size distribution. Tauc’s equation was used to estimate
the band gap energy of calcined CeO2–NPs:
(αhν)n = B(hν-Eg) (2)
where B is a constant, hν is the photon energy, α is the absorption coefficient, n is 2 for the direct
transitions, and Eg (i.e., band gap energy) is the spot of the junction of the Tau plot slope on
the x-axis [32,33]. According to Figure 5b, the calculated band gap energies for the CeO2-NPs prepared
by PAA15000 and PAA17000 were 2.47 and 2.52 eV, respectively. These samples showed a strong red
shift in the band gap as compared with the bulk cerium oxide (Eg = 3.19 eV) [34]. On the other hand,
the samples with PAA65000 had a band gap energy of 3.51 eV, greater than that of the bulk CeO2, and
indicative of the blue shift in the band gap as a result of quantum confinement [35]. A decrease in
the PAA molecular weight from 65,000 g/mol to 15,000 g/mol was obviously associated with a red shift
in λmax, which could be due to agglomeration and wide particle size distribution. This observation can
be explained partly by the fact that typical direct semiconductors indicate a blue shift in λmax if their
particle sizes reduce [33,36]. λmax and crystallite size are summarized in Table 1.
Figure 5. Optical absorption (a) and Tauc plot (b) of CeO2-NPs.
Polymers 2020, 12, 1444 9 of 14
Table 1. Molecular weight, optical properties, and particle size of nanoceria.
PAA Molecular Weight
in CeO2-NPs, g/mole
λmax, nm Eg, eV
Crystallite Size (nm)
Calculated 1 Observed 2
15,000 348 2.47 12.26 46.24
17,000 354 2.52 13.66 28.58
65,000 298 3.51 15.04 45.52
1 The mean crystallite sizes (D) of CeO2–NPs were determined by the Debye–Scherrer formula. 2 The mean particle
sizes of CeO2–NPs were obtained by the FESEM images.
3.6. Biocompatibility of the Synthesized Samples
In the human body, the erythrocytes exist in great quantities and possess large amounts of
biological and morphological characteristics. Therefore, these cells have been vastly used in drug
transport. The main target of the polyunsaturated fatty acids as well as hemoglobin molecules, known
as redox-active oxygen transport molecules and potent promoters of activated oxygen species, is
the erythrocytes. Oxidative damage to their membrane lipids and proteins can account for hemolysis
that further causes several complications, such as oxidative drugs and excess of transition metals [37].
Moreover, hemolysis is more likely to induce anemia in different medical conditions [38,39]. This
experiment was applied to evaluate if synthesized nanoceria could mutilate the erythrocyte membrane,
given some previous reports concerning the toxicity of the CeO2-NPs [40,41]. The results in Figure 6
indicated that the CeO2–NPs prepared by PAA had potent hemolytic actions in a dose-dependent
manner. The lysis of erythrocytes was found to decrease significantly as the concentration of the NPs
increased (p < 0.001). At an identical concentration, the CeO2–NPs with PAA15000 exhibited maximum
hemolysis, whereas the CeO2–NPs with PAA65000 inhibited hemolytic activity to the greatest extent.
The HC50 values are shown in Table 2. The highest HC50 was for the sample prepared with PAA65000
(7.35 ± 1.32 mg/mL). This finding implies that less damage occurred following the use of the CeO2-NPs
with PAA65000, which may be attributed to their λmax < 299 nm and high amounts of Ce3+ on
the surface. Besides, this in vitro test revealed the biocompatibility of the synthesis of nanoceria using
PAA65000, which makes them promising for future drug development and biomedical applications,
such as the treatment of cancer.
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Table 2. Molecular weight, 50% hemolytic concentration (HC50), and half-maximal inhibitory






15,000 0.022 ± 0.001 17.44 ± 7.32 8.09 ± 1.55
17,000 3.74 ± 0.58 6.17 ± 1.01 2.11 ± 0.33
65,000 7.35 ± 1.32 0.12 ± 0.03 0.20 ± 0.01
3.7. Anticancer Activity of Nanoceria
A body of literature shows nanoceria acts as a regenerative radical scavenger that can produce
the active Ce3+ oxidation state for inhibition of free radicals. This characteristic differentiates them from
other nano-sized materials with antioxidant effects, namely hydroxylated and water-soluble C-60 and
SWCNTs [42–44]. Free radicals and ROS are found to be involved throughout degenerative processes,
like cancer, mostly owing to their capacity to impair cell membranes, DNA, and proteins [45,46]. Hence,
nanoceria can afford to block the production of ROS and free radicals and prevent free radical-associated
diseases. Nanoceria seem to carry anticancer effects in some cellular models by the mechanisms of
oxidative stress and apoptosis while protecting normal cells [34]. In this study, the anticancer properties
of the nanoceria against two cancer cell lines, the breast cancer cell line (MCF-7) and cervical carcinoma
cell line (HeLa), were evaluated. In Figure 7, the results of cytotoxicity are shown at the concentration
between 0.50 and 250 µg/mL of the CeO2-NPs. Overall, as the concentrations of the nanoceria increased,
the viability of both cancer cells decreased significantly (p < 0.001). The proliferation of MCF-7 was
affected by 50% at 17.44 ± 7.32, 6.17 ± 1.68, and 0.12 ± 0.03 µg/mL for the samples with PAA15000,
PAA17000, and PAA65000, respectively. When HeLa cells were exposed to the nanoceria prepared by
PAA15000, PAA17000, and PAA65000, the respective IC50 values were 8.09 ± 1.55, 2.11 ± 0.33, and
0.20 ± 0.01 µg/mL. Therefore, not only could the CeO2-NPs with PAA65000 counteract the growth
of cancerous cells effectively, but almost no lysis also occurred in RBCs at 0.12 ± 0.03 and 0.20 ±
0.01 µg/mL.
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Figure 7. In vitro cytotoxicity of CeO2–NPs after 24 h of incubation with different concentrations of
CeO2–NP prepared by (a) PAA15000, (b) PAA17000, (c) PAA65000.
4. Conclusions
The CeO2-NPs were prepared by a sol–gel method, using PAA with different molecular weights
(15,000, 17,000, and 65,000 g/mL) as an organic template. The structural analyses exhibited that
the calcined ceria at 400 ◦C had nano-sized particles <50 nm. The FTIR spectroscopy confirmed no trace
amount of nitrate that can explain the notable biocompatibility of the NPs. Moreover, the CeO2-NPs
had anticancer effects on the viability of both MCF7 and HeLa cells. The NPs prepared by the use of
PAA65000 resulted in a narrower distribution of particle size, marked cytotoxicity against cancer cell
lines, and almost no RBC lysis at IC50. The in vitro test on erythrocytes revealed the biocompatibility
of the CeO2-NPs prepared with PAA65000, which makes them a good candidate for prospective
biomedical applications, such as cancer therapy.
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